BioSig Technologies, Inc. STEX Change In Fair Value Of Embedded Derivative
Change In Fair Value Of Embedded Derivative at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept STEX:ChangeInFairValueOfEmbeddedDerivative.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s change in fair value of embedded derivative.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s change in fair value of embedded derivative?
- BioSig Technologies, Inc. (STEX) reported change in fair value of embedded derivative of -$497K in Q1 2026.
- How has BioSig Technologies, Inc.'s change in fair value of embedded derivative changed year-over-year?
- BioSig Technologies, Inc.'s change in fair value of embedded derivative increased by 71.7% year-over-year, from -$1.75M to -$497K.
- What does change in fair value of embedded derivative mean?
- This metric tracks the periodic adjustments in the fair value of derivative components embedded within host contracts, such as convertible debt or complex financing agreements. Fluctuations here reflect market-driven changes in the valuation of these embedded features rather than operational performance. It is essential for understanding the volatility introduced into the income statement by complex capital structures.